Drugs Targeting BRAF

TAFLINAR (dabrafenib) with MEKINIST (trametinib)

BRAF is another gene that can change in NSCLC. These two oral drugs are approved in combination for NSCLC with a change in BRAF called V600E. The drugs are approved only for cancer that has spread.